Literature DB >> 14620606

ATS, CDC, and IDSA update recommendations on the treatment of tuberculosis.

Matthew Neff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14620606

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN： 0002-838X            Impact factor:   3.292


× No keyword cloud information.
  10 in total

Review 1.  The chemical biology of new drugs in the development for tuberculosis.

Authors:  Clifton E Barry; John S Blanchard
Journal:  Curr Opin Chem Biol       Date:  2010-05-07       Impact factor: 8.822

2.  Cefsulodin Inspired Potent and Selective Inhibitors of mPTPB, a Virulent Phosphatase from Mycobacterium tuberculosis.

Authors:  Rongjun He; Zhi-Hong Yu; Ruo-Yu Zhang; Li Wu; Andrea M Gunawan; Zhong-Yin Zhang
Journal:  ACS Med Chem Lett       Date:  2015-11-03       Impact factor: 4.345

3.  Diversity-Oriented Synthesis for Novel, Selective and Drug-like Inhibitors for a Phosphatase from Mycobacterium Tuberculosis.

Authors:  Rongjun He; Yunpeng Bai; Zhi-Hong Yu; Li Wu; Andrea Michelle Gunawan; Zhong-Yin Zhang
Journal:  Medchemcomm       Date:  2014-10       Impact factor: 3.597

4.  Organocatalytic multicomponent reaction for the acquisition of a selective inhibitor of mPTPB, a virulence factor of tuberculosis.

Authors:  Rongjun He; Li-Fan Zeng; Yantao He; Li Wu; Andrea Michelle Gunawan; Zhong-Yin Zhang
Journal:  Chem Commun (Camb)       Date:  2013-03-11       Impact factor: 6.222

5.  The three RelE homologs of Mycobacterium tuberculosis have individual, drug-specific effects on bacterial antibiotic tolerance.

Authors:  Ramandeep Singh; Clifton E Barry; Helena I M Boshoff
Journal:  J Bacteriol       Date:  2010-01-08       Impact factor: 3.490

6.  HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients.

Authors:  Ken Tashiro; Nobuyuki Horita; Kenjiro Nagai; Misako Ikeda; Masaharu Shinkai; Masaki Yamamoto; Takashi Sato; Yu Hara; Hideyuki Nagakura; Yuji Shibata; Hiroki Watanabe; Kentaro Nakashima; Ryota Ushio; Akimichi Nagashima; Atsuya Narita; Nobuaki Kobayashi; Makoto Kudo; Takeshi Kaneko
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

7.  The Platelet Count Can Predict In-hospital Death in HIV-negative Smear-positive Pulmonary Tuberculosis Inpatients.

Authors:  Hideto Goto; Nobuyuki Horita; Ken Tashiro; Kenjiro Nagai; Masaki Yamamoto; Takashi Sato; Yu Hara; Hideyuki Nagakura; Yuji Shibata; Hiroki Watanabe; Kentaro Nakashima; Ryota Ushio; Akimichi Nagashima; Misako Ikeda; Atsuya Narita; Katsuhito Sasaki; Nobuaki Kobayashi; Makoto Kudo; Takeshi Kaneko
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

8.  Metagenomic analysis of the lung microbiome in pulmonary tuberculosis - a pilot study.

Authors:  Yongfeng Hu; Min Cheng; Bo Liu; Jie Dong; Lilian Sun; Jian Yang; Fan Yang; Xinchun Chen; Qi Jin
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

9.  Age, Dehydration, Respiratory Failure, Orientation Disturbance, and Blood Pressure Score Predicts In-hospital Mortality in HIV-negative Non-multidrug-resistant Smear-positive Pulmonary Tuberculosis in Japan.

Authors:  Kenjiro Nagai; Nobuyuki Horita; Takashi Sato; Masaki Yamamoto; Hideyuki Nagakura; Takeshi Kaneko
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

10.  Factors for Predicting Outcomes among Non-HIV Patients with Pulmonary Tuberculosis.

Authors:  Toshinori Tsukahara; Nobuyuki Horita; Ken Tashiro; Kenjiro Nagai; Masaharu Shinkai; Masaki Yamamoto; Takashi Sato; Yu Hara; Hideyuki Nagakura; Yuji Shibata; Hiroki Watanabe; Kentaro Nakashima; Ryota Ushio; Akimichi Nagashima; Misako Ikeda; Atsuya Narita; Katsuhito Sasaki; Nobuaki Kobayashi; Makoto Kudo; Takeshi Kaneko
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.